Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies — a EuroFlow study

1. Verbeek, M.W.C.
2. Buracchi, C.
3. Laqua, A.
4. Nierkens, S.
5. Sedek, L.
6. Flores-Montero, J.
7. Hofmans, M.
8. Sobral de Costa, E.
9. Nováková, M.
10. Mejstrikova, E.
11. Barrena, S.
12. Kohlscheen, S.
13. Szczepanowski, M.
14. Kulis, J.
15. Oliveira, E.
16. Jugooa, R.
17. de Jong, A.X.
18. Szczepanski, T.
19. Philippé, J.
20. van Dongen, J.J.M.
21. Orfao, A.
22. Brüggemann, M.
23. Gaipa, G.
24. van der Velden, V.H.J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1111/BJH.17992 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus